Mentari Therapeutics, Inc. (MTRI)
14.48
-0.76
(-5.02%)
USD |
NASDAQ |
Nov 20, 10:35
Mentari Therapeutics Cash from Operations (Quarterly) : -1.142M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.142M |
| June 30, 2026 | -2.909M |
| March 31, 2026 | -1.759M |
| December 31, 2025 | -2.028M |
| September 30, 2025 | -1.931M |
| June 30, 2025 | -2.322M |
| March 31, 2025 | -1.562M |
| December 31, 2024 | -2.448M |
| September 30, 2024 | -1.827M |
| June 30, 2024 | -0.9629M |
| March 31, 2024 | -1.964M |
| December 31, 2023 | -1.817M |
| September 30, 2023 | -2.174M |
| June 30, 2023 | -0.7367M |
| March 31, 2023 | -1.655M |
| December 31, 2022 | -2.618M |
| September 30, 2022 | -2.256M |
| June 30, 2022 | -3.989M |
| March 31, 2022 | -5.274M |
| December 31, 2021 | -3.532M |
| September 30, 2021 | -2.654M |
| June 30, 2021 | -2.198M |
| March 31, 2021 | -5.598M |
| December 31, 2020 | -1.063M |
| September 30, 2020 | -1.372M |
| Date | Value |
|---|---|
| June 30, 2020 | -1.244M |
| March 31, 2020 | -1.471M |
| December 31, 2019 | -2.066M |
| September 30, 2019 | -2.365M |
| June 30, 2019 | -1.768M |
| March 31, 2019 | -2.077M |
| December 31, 2018 | -1.391M |
| September 30, 2018 | -1.317M |
| June 30, 2018 | -1.006M |
| March 31, 2018 | -0.7511M |
| December 31, 2017 | -0.786M |
| September 30, 2017 | -1.076M |
| June 30, 2017 | -0.7358M |
| March 31, 2017 | -0.7426M |
| December 31, 2016 | -0.6439M |
| September 30, 2016 | -0.1663M |
| June 30, 2016 | -0.1126M |
| March 31, 2016 | -0.0349M |
| December 31, 2015 | -0.1092M |
| September 30, 2015 | -0.1308M |
| June 30, 2015 | -0.755M |
| March 31, 2015 | -0.6728M |
| December 31, 2014 | -0.0881M |
| September 30, 2014 | -0.1053M |
| June 30, 2014 | -0.6247M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Liquidia Corp. | 146.68M |
| Johnson & Johnson | 7.72B |
| Eli Lilly & Co. | 11.40B |
| Merck & Co., Inc. | 6.558B |
| ANI Pharmaceuticals, Inc. | 83.79M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.0024M |
| Cash from Financing (Quarterly) | 0.04M |
| Free Cash Flow | -7.839M |
| Free Cash Flow Per Share (Quarterly) | -0.2089 |
| Free Cash Flow to Equity (Quarterly) | -1.142M |
| Free Cash Flow to Firm (Quarterly) | -1.142M |
| Free Cash Flow Yield | -9.85% |